Recent

% | $
Quotes you view appear here for quick access.

Halozyme Therapeutics, Inc. Message Board

  • fezziwig2008 fezziwig2008 Apr 25, 2013 12:11 PM Flag

    NCCN Oncology Research Program- Nice to See NCCN Director Buying HALO- Pancreatic CA Specialist

    NCCN develops the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), a widely used set of clinical recommendations about cancer treatment; the NCCN Guidelines for Patients®, which include the same information your doctors use to diagnose and treat cancer, translated into language you and your family can understand; the NCCN Treatment Summaries for People With Cancer™, the NCCN Drugs & Biologics Compendium (NCCN Compendium®), a compilation of cancer drugs derived from the NCCN Guidelines that supports decision-making about the use of cancer medications; and the NCCN Chemotherapy Order Templates (NCCN Templates®), a library of chemotherapy order templates developed to improve the safe and effective use of drugs and biologics in cancer care. NCCN also publishes JNCCN — The Journal of the National Comprehensive Cancer Network; develops continuing medical education courses for oncologists and other clinicians; runs the NCCN Oncology Research Program (ORP); and organizes meetings for clinicians and others.

    Margaret Tempero, NCCN, UCSF Director Pancreatic Ca Center, and HALO Investor

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
HALO
10.07+0.37(+3.81%)May 25 4:00 PMEDT